Markets
Aquestive Therapeutics at H.C. Wainwright: ANAPHYLM Launch Takes Center Stage
Aquestive Therapeutics took the spotlight at the H.C. Wainwright Global Investment Conference with its ANAPHYLM commercial launch front and center — a pivotal inflection point that could redefine the company's revenue trajectory and stock narrative through the rest of 2026.